Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore

Investigational New Drugs

  • h-index: 110
  • Total citations: 100,491
  • Total papers: 3,706
  • Impact factor: 2.7523364485981308

Homepage: https://www.springer.com/journal/10637

Investigational New Drugs

Journal
Visit website →
H-Index = 110
Citations = 100.49K+

Papers

Evidence

Recent papers in Investigational New Drugs

  1. Qishen Yiqi Dripping Pills ameliorate doxorubicin-induced cardiotoxicity: a study based on bioinformatics and experimental verificationInvestigational New Drugs · Fri,
  2. Novel EGFR tyrosine kinase inhibitors exhibiting intrinsic fluorescenceInvestigational New Drugs · Thu,
  3. The novel agent VP79s synergistically enhances venetoclax activity in multiple myeloma cellsInvestigational New Drugs · Fri,
  4. Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancerInvestigational New Drugs · Wed,
  5. Phase I results on the efficacy, safety and pharmacokinetics of lurbinectedin and irinotecan in advanced solid tumorsInvestigational New Drugs · Wed,
  6. A phase 1b/2 study of intermittent talazoparib plus temozolomide in patients with metastatic castration-resistant prostate cancer and no mutations in DNA damage response genesInvestigational New Drugs · Thu,
  7. Pharmacokinetics, efficacy and safety of palbociclib and fulvestrant in a patient with hormone receptor-positive, human epidermal growth factor receptor 2 negative metastatic breast cancer with end-stage renal disease undergoing hemodialysis: A case reportInvestigational New Drugs · Thu,
  8. Synergistic effects of the curcumin analog HO-3867 and olaparib in transforming fallopian tube epithelial cellsInvestigational New Drugs · Mon,
  9. Assessing the risks and benefits of investigational new drugs in adult phase-I oncology trials in China, 2013–2021Investigational New Drugs · Fri,
  10. Safety and efficacy of semi-dose venetoclax plus azacitidine in unfit acute myeloid leukemia patients in China: a real-world single-center studyInvestigational New Drugs · Mon,

About Investigational New Drugs

Investigational New Drugs carries 3,706 indexed papers, 100,491 citations, h-index 110 in Synapse's enriched corpus. Each paper indexed here includes structured clinical evidence extraction (PICO), methodology classification with level of evidence, and links to related guideline recommendations where applicable.

On Synapse's credibility score (derived from SJR ranking and cross-citation patterns), Investigational New Drugs sits among the highest-credibility cardiovascular journals.

The journal's official homepage is at https://www.springer.com/journal/10637.

Use the feed below to follow new Investigational New Drugs publications with AI-enriched analysis — each paper is decomposed into study design, population, intervention, comparator, primary outcome, and key finding, with the underlying evidence traceable to the primary source.

Deterministic synthesis from Synapse's enriched records — 105 words.